Catalyst Pharmaceuticals, Inc. (CPRX)

Catalyst Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	652.8	517.55	137.64	298.4	171.45	130.24
Short-Term Investments	-	-	-	-	19.82	10.04
Cash & Short-Term Investments	652.8	517.55	137.64	298.4	191.27	140.28
Cash Growth	73.76%	276.03%	-53.87%	56.01%	36.35%	48.41%
Accounts Receivable	65.89	65.49	53.65	10.79	6.72	6.42
Other Receivables	0.43	-	-	-	-	-
Receivables	66.31	65.49	53.65	10.79	6.72	6.42
Inventory	18.65	19.54	15.64	6.81	7.87	4.65
Prepaid Expenses	19.73	20	12.05	4.32	3.92	7.45
Other Current Assets	1.24	1.03	0.35	0.49	0.33	0.45
Total Current Assets	758.74	623.61	219.33	320.81	210.11	159.24
Property, Plant & Equipment	3.23	3.58	3.7	3.62	3.98	0.13
Long-Term Investments	21.26	21.56	16.49	-	-	-
Other Intangible Assets	137.98	156.67	194.05	32.47	-	-
Long-Term Deferred Tax Assets	50.7	45.98	36.54	18.74	23.7	32.97
Other Long-Term Assets	-	-	-	-	0.01	0.01
Total Assets	971.92	851.41	470.11	375.63	237.79	192.35
Accounts Payable	5.53	16.59	14.8	3.98	2.77	4.26
Accrued Expenses	41.76	53.85	40.29	27.83	21.95	17.4
Current Portion of Leases	0.42	0.4	0.37	0.34	0.31	0.03
Current Income Taxes Payable	0.44	0.89	0.73	8.7	0.08	-
Other Current Liabilities	64.86	48.94	19.88	16.75	1.96	1.07
Total Current Liabilities	113.01	120.68	76.06	57.59	27.06	22.76
Long-Term Leases	2.57	2.79	3.19	3.56	3.89	-
Other Long-Term Liabilities	0.31	0.32	2.98	14.06	-	-
Total Liabilities	115.89	123.78	82.23	75.21	30.96	22.76
Common Stock	0.12	0.12	0.11	0.11	0.1	0.1
Additional Paid-In Capital	461.87	442.29	266.49	250.43	233.19	223.17
Retained Earnings	394.01	285.16	121.27	49.86	-26.31	-53.71
Comprehensive Income & Other	0.03	0.06	0.01	0.02	-0.15	0.03
Shareholders' Equity	856.03	727.63	387.88	300.42	206.83	169.6
Total Liabilities & Equity	971.92	851.41	470.11	375.63	237.79	192.35
Total Debt	2.99	3.19	3.56	3.89	4.2	0.03
Net Cash (Debt)	649.81	514.37	134.08	294.5	187.06	140.25
Net Cash Growth	74.53%	283.63%	-54.47%	57.43%	33.38%	49.89%
Net Cash Per Share	5.13	4.12	1.18	2.64	1.74	1.32
Filing Date Shares Outstanding	122.39	121.45	117.86	105.65	102.74	103.82
Total Common Shares Outstanding	122.39	120.88	107.12	105.26	102.99	103.78
Working Capital	645.73	502.93	143.27	263.22	183.04	136.49
Book Value Per Share	6.99	6.02	3.62	2.85	2.01	1.63
Tangible Book Value	718.04	570.96	193.83	267.95	206.83	169.6
Tangible Book Value Per Share	5.87	4.72	1.81	2.55	2.01	1.63
Machinery	1.08	1.05	0.49	0.27	0.25	0.29
Leasehold Improvements	0.99	0.99	0.99	0.98	0.98	0.18

Updated May 7, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q